Literature DB >> 3262193

Enhancement of human immunodeficiency virus production by natural lymphotoxin.

T Matsuyama1, Y Hamamoto, S Kobayashi, M Kurimoto, J Minowada, N Kobayashi, N Yamamoto.   

Abstract

The effect of natural lymphotoxin (n-LT) on CD4+ MOLT-4 cells and those cells producing human immunodeficiency virus (HIV), MOLT-4/HIVHTLV-IIIB cells, was studied. Four days after treatment with n-LT, a significant cytotoxic/cytostatic effect was observed predominantly on MOLT-4/HIVHTLV-IIIB cells. Furthermore, with regard to the production of HIV, an almost 3- to 5-fold increase of viral particles was observed in MOLT-4/HIVHTLV-IIIB cells 6 h after treatment with n-LT. These data indicate the possibility that this cytotoxic factor is one of the responsible molecules in the pathogenesis of the acquired immunodeficiency syndrome (AIDS).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3262193     DOI: 10.1007/bf00211217

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  16 in total

1.  Human B cell, T cell and null cell leukaemic cell lines derived from acute lymphoblastic leukaemias.

Authors:  I Miyoshi; S Hiraki; T Tsubota; I Kubonishi; Y Matsuda; T Nakayama; H Kishimoto; I Kimura; H Masuji
Journal:  Nature       Date:  1977-06-30       Impact factor: 49.962

2.  Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay.

Authors:  S Harada; Y Koyanagi; N Yamamoto
Journal:  Science       Date:  1985-08-09       Impact factor: 47.728

3.  Proposal of standardized methods and reference for assaying recombinant human tumor necrosis factor.

Authors:  S Yamazaki; E Onishi; K Enami; K Natori; M Kohase; H Sakamoto; M Tanouchi; H Hayashi
Journal:  Jpn J Med Sci Biol       Date:  1986-06

4.  Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes.

Authors:  J Minowada; T Onuma; G E Moore
Journal:  J Natl Cancer Inst       Date:  1972-09       Impact factor: 13.506

5.  Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells.

Authors:  I Miyoshi; I Kubonishi; S Yoshimoto; T Akagi; Y Ohtsuki; Y Shiraishi; K Nagata; Y Hinuma
Journal:  Nature       Date:  1981-12-24       Impact factor: 49.962

6.  Identification of human lymphocyte-derived lymphotoxins with binding and cell-lytic activity on NK-sensitive cell lines in vitro.

Authors:  M L Weitzen; R S Yamamoto; G A Granger
Journal:  Cell Immunol       Date:  1983-04-01       Impact factor: 4.868

7.  Role of lymphotoxin in antibody-dependent cell-mediated cytotoxicity (ADCC).

Authors:  L L Kondo; W Rosenau; D W Wara
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

8.  Mechanisms of lymphocyte-mediated cytotoxicity. III. Characterization of the mechanism of inhibition of the human alloimmune lymphocyte-mediated cytotoxic reaction by polyspecific anti-lymphotoxin sera in vitro.

Authors:  C F Ware; G A Granger
Journal:  J Immunol       Date:  1981-05       Impact factor: 5.422

9.  Antiviral effects of recombinant tumour necrosis factor in vitro.

Authors:  J Mestan; W Digel; S Mittnacht; H Hillen; D Blohm; A Möller; H Jacobsen; H Kirchner
Journal:  Nature       Date:  1986 Oct 30-Nov 5       Impact factor: 49.962

10.  Cytotoxicity mediated by soluble antigen and lymphocytes in delayed hypersensitivity. 3. Analysis of mechanism.

Authors:  N H Ruddle; B H Waksman
Journal:  J Exp Med       Date:  1968-12-01       Impact factor: 14.307

View more
  9 in total

Review 1.  Is TNF involved in the progression of AIDS?

Authors:  N Kobayashi; Y Hamamoto; N Yamamoto
Journal:  Virus Genes       Date:  1990-07       Impact factor: 2.332

2.  A novel cis-acting element that controls transcription of human immunodeficiency virus type 1 DNA, depending on cell type.

Authors:  Y Nakanishi; Y Masamune; N Kobayashi
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

3.  Cytocidal effect of tumor necrosis factor on cells chronically infected with human immunodeficiency virus (HIV): enhancement of HIV replication.

Authors:  T Matsuyama; Y Hamamoto; G Soma; D Mizuno; N Yamamoto; N Kobayashi
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

4.  Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication.

Authors:  N Kobayashi; Y Hamamoto; N Yamamoto; A Ishii; M Yonehara; S Yonehara
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

5.  Production of tumor necrosis factors by human T cell lines infected with HTLV-1 may cause their high susceptibility to human immunodeficiency virus infection.

Authors:  N Kobayashi; Y Hamamoto; N Yamamoto
Journal:  Med Microbiol Immunol       Date:  1990       Impact factor: 3.402

6.  The presence of HTLV-I proviral DNA in the central nervous system of patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.

Authors:  J Kira
Journal:  Mol Neurobiol       Date:  1994 Apr-Jun       Impact factor: 5.590

7.  Altered production of tumour necrosis factors alpha and beta and interferon gamma by HIV-infected individuals.

Authors:  A Vyakarnam; P Matear; A Meager; G Kelly; B Stanley; I Weller; P Beverley
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

8.  Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat.

Authors:  E J Duh; W J Maury; T M Folks; A S Fauci; A B Rabson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

9.  Membrane tumor necrosis factor (TNF) induced cooperative signaling of TNFR60 and TNFR80 favors induction of cell death rather than virus production in HIV-infected T cells.

Authors:  J K Lazdins; M Grell; M R Walker; K Woods-Cook; P Scheurich; K Pfizenmaier
Journal:  J Exp Med       Date:  1997-01-06       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.